Several vaccine companies say they are expecting breakthroughs as early as this year as they pursue new ways to protect people against SARS-CoV-2, the virus that causes COVID-19. The Food and Drug Administration is set to convene a panel of its outside vaccine advisers later this month to weigh key issues over the future of COVID-19 vaccines, including […]

While biopharma giants showed mixed results in 2022 trying to treat breast cancer with selective ER degraders (SERDs), a much smaller drug developer is preparing to test a two-prong approach to beating the disease in a pivotal trial. Olema Oncology plans in mid-year to launch a Phase III study for its lead candidate OP-1250 that […]

JP Morgan week is – knock on wood – shaping up to approximate pre-pandemic attendance levels, as executives return to San Francisco after two years of COVID-19-enforced absences. “The JP Morgan Healthcare Conference continues to set the tone in healthcare for the coming year,” said Mark Klausner, managing partner at ICR Westwicke. Nonetheless, this year […]